<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-06-01" modified="2017-12-20" version="200">
<accession>Q05655</accession>
<accession>B0KZ81</accession>
<accession>B2R834</accession>
<accession>Q15144</accession>
<accession>Q86XJ6</accession>
<name>KPCD_HUMAN</name>
<protein>
<recommendedName>
<fullName>Protein kinase C delta type</fullName>
<ecNumber evidence="28">2.7.11.13</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Tyrosine-protein kinase PRKCD</fullName>
<ecNumber>2.7.10.2</ecNumber>
</alternativeName>
<alternativeName>
<fullName>nPKC-delta</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>Protein kinase C delta type regulatory subunit</fullName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Protein kinase C delta type catalytic subunit</fullName>
</recommendedName>
<alternativeName>
<fullName>Sphingosine-dependent protein kinase-1</fullName>
<shortName>SDK1</shortName>
</alternativeName>
</component>
</protein>
<gene>
<name type="primary">PRKCD</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Biochim. Biophys. Acta" volume="1174" first="171" last="181">
<title>Molecular and biochemical characterization of a recombinant human PKC-delta family member.</title>
<authorList>
<person name="Aris J.P."/>
<person name="Basta P.V."/>
<person name="Holmes W.D."/>
<person name="Ballas L.M."/>
<person name="Moomaw C."/>
<person name="Rankl N.B."/>
<person name="Blobel G."/>
<person name="Loomis C.R."/>
<person name="Burns D.J."/>
</authorList>
<dbReference type="PubMed" id="8357834"/>
<dbReference type="DOI" id="10.1016/0167-4781(93)90111-P"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS SER-375 AND MET-593</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="1993-03" db="EMBL/GenBank/DDBJ databases">
<title>Partial cDNA Sequence of human protein kinase C delta.</title>
<authorList>
<person name="Hug H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-365 (ISOFORM 1)</scope>
<source>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="Genes Cells" volume="2" first="601" last="614">
<title>Functional analyses of mammalian protein kinase C isozymes in budding yeast and mammalian fibroblasts.</title>
<authorList>
<person name="Nomoto S."/>
<person name="Watanabe Y."/>
<person name="Ninomiya-Tsuji J."/>
<person name="Yang L.-X."/>
<person name="Kikuchi K."/>
<person name="Hagiwara M."/>
<person name="Hidaka H."/>
<person name="Matsumoto K."/>
<person name="Irie K."/>
</authorList>
<dbReference type="PubMed" id="9427282"/>
<dbReference type="DOI" id="10.1046/j.1365-2443.1997.1470346.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 51-676 (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2008" name="Biochemistry" volume="47" first="787" last="797">
<title>Identification of a novel antiapoptotic human protein kinase C delta isoform, PKCdeltaVIII in NT2 cells.</title>
<authorList>
<person name="Jiang K."/>
<person name="Apostolatos A.H."/>
<person name="Ghansah T."/>
<person name="Watson J.E."/>
<person name="Vickers T."/>
<person name="Cooper D.R."/>
<person name="Epling-Burnette P.K."/>
<person name="Patel N.A."/>
</authorList>
<dbReference type="PubMed" id="18092819"/>
<dbReference type="DOI" id="10.1021/bi7019782"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 224-371 (ISOFORM 2)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1994" name="FEBS Lett." volume="356" first="5" last="8">
<title>Identification of multiple, novel, protein kinase C-related gene products.</title>
<authorList>
<person name="Palmer R.H."/>
<person name="Ridden J."/>
<person name="Parker P.J."/>
</authorList>
<dbReference type="PubMed" id="7988719"/>
<dbReference type="DOI" id="10.1016/0014-5793(94)01202-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 432-533 (ISOFORM 1)</scope>
<scope>VARIANT VAL-494</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="J. Cell. Physiol." volume="189" first="306" last="315">
<title>Regulation of human eosinophil NADPH oxidase activity: a central role for PKCdelta.</title>
<authorList>
<person name="Bankers-Fulbright J.L."/>
<person name="Kita H."/>
<person name="Gleich G.J."/>
<person name="O'Grady S.M."/>
</authorList>
<dbReference type="PubMed" id="11748588"/>
<dbReference type="DOI" id="10.1002/jcp.10022"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="Biochem. J." volume="361" first="255" last="265">
<title>Phosphorylation of the protein kinase C-theta activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phosphorylation is critical to in vivo nuclear-factor-kappaB induction.</title>
<authorList>
<person name="Liu Y."/>
<person name="Graham C."/>
<person name="Li A."/>
<person name="Fisher R.J."/>
<person name="Shaw S."/>
</authorList>
<dbReference type="PubMed" id="11772397"/>
</citation>
<scope>MUTAGENESIS OF THR-507</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="Biochemistry" volume="41" first="561" last="569">
<title>Regulation of both PDK1 and the phosphorylation of PKC-zeta and -delta by a C-terminal PRK2 fragment.</title>
<authorList>
<person name="Hodgkinson C.P."/>
<person name="Sale G.J."/>
</authorList>
<dbReference type="PubMed" id="11781095"/>
<dbReference type="DOI" id="10.1021/bi010719z"/>
</citation>
<scope>INTERACTION WITH PDPK1</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="17616" last="17622">
<title>Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling.</title>
<authorList>
<person name="Ren J."/>
<person name="Li Y."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="11877440"/>
<dbReference type="DOI" id="10.1074/jbc.M200436200"/>
</citation>
<scope>INTERACTION WITH MUC1</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="1431" last="1441">
<title>Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9.</title>
<authorList>
<person name="Yoshida K."/>
<person name="Wang H.-G."/>
<person name="Miki Y."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="12628935"/>
<dbReference type="DOI" id="10.1093/emboj/cdg134"/>
</citation>
<scope>INTERACTION WITH RAD9A</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="23643" last="23652">
<title>Roles of tyrosine phosphorylation and cleavage of protein kinase Cdelta in its protective effect against tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis.</title>
<authorList>
<person name="Okhrimenko H."/>
<person name="Lu W."/>
<person name="Xiang C."/>
<person name="Ju D."/>
<person name="Blumberg P.M."/>
<person name="Gomel R."/>
<person name="Kazimirsky G."/>
<person name="Brodie C."/>
</authorList>
<dbReference type="PubMed" id="15774464"/>
<dbReference type="DOI" id="10.1074/jbc.M501374200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT TYR-155</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Blood" volume="108" first="4035" last="4044">
<title>PKCdelta regulates collagen-induced platelet aggregation through inhibition of VASP-mediated filopodia formation.</title>
<authorList>
<person name="Pula G."/>
<person name="Schuh K."/>
<person name="Nakayama K."/>
<person name="Nakayama K.I."/>
<person name="Walter U."/>
<person name="Poole A.W."/>
</authorList>
<dbReference type="PubMed" id="16940418"/>
<dbReference type="DOI" id="10.1182/blood-2006-05-023739"/>
</citation>
<scope>FUNCTION IN PLATELET AGGREGATION</scope>
<scope>INTERACTION WITH VASP</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="Biochem. J." volume="406" first="501" last="509">
<title>Coincident regulation of PKCdelta in human platelets by phosphorylation of Tyr311 and Tyr565 and phospholipase C signalling.</title>
<authorList>
<person name="Hall K.J."/>
<person name="Jones M.L."/>
<person name="Poole A.W."/>
</authorList>
<dbReference type="PubMed" id="17570831"/>
<dbReference type="DOI" id="10.1042/BJ20070244"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-313 AND TYR-567</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="FEBS Lett." volume="581" first="3377" last="3381">
<title>Novel phosphorylation site markers of protein kinase C delta activation.</title>
<authorList>
<person name="Durgan J."/>
<person name="Michael N."/>
<person name="Totty N."/>
<person name="Parker P.J."/>
</authorList>
<dbReference type="PubMed" id="17603046"/>
<dbReference type="DOI" id="10.1016/j.febslet.2007.06.035"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION AT SER-299; SER-302 AND SER-304</scope>
<scope>MUTAGENESIS OF SER-299</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Mol. Cancer Res." volume="5" first="627" last="639">
<title>The localization of protein kinase Cdelta in different subcellular sites affects its proapoptotic and antiapoptotic functions and the activation of distinct downstream signaling pathways.</title>
<authorList>
<person name="Gomel R."/>
<person name="Xiang C."/>
<person name="Finniss S."/>
<person name="Lee H.K."/>
<person name="Lu W."/>
<person name="Okhrimenko H."/>
<person name="Brodie C."/>
</authorList>
<dbReference type="PubMed" id="17579121"/>
<dbReference type="DOI" id="10.1158/1541-7786.MCR-06-0255"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Protein Sci." volume="16" first="2711" last="2715">
<title>Protein kinase C delta is phosphorylated on five novel Ser/Thr sites following inducible overexpression in human colorectal cancer cells.</title>
<authorList>
<person name="Welman A."/>
<person name="Griffiths J.R."/>
<person name="Whetton A.D."/>
<person name="Dive C."/>
</authorList>
<dbReference type="PubMed" id="17965192"/>
<dbReference type="DOI" id="10.1110/ps.072874607"/>
</citation>
<scope>PHOSPHORYLATION AT THR-50; THR-141; SER-304; THR-451; SER-506; THR-507 AND SER-664</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299; TYR-313; SER-503; SER-654; SER-658 AND SER-664</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="2608" last="2625">
<title>Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cdelta elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA.</title>
<authorList>
<person name="Doller A."/>
<person name="Akool E.-S."/>
<person name="Huwiler A."/>
<person name="Mueller R."/>
<person name="Radeke H.H."/>
<person name="Pfeilschifter J."/>
<person name="Eberhardt W."/>
</authorList>
<dbReference type="PubMed" id="18285462"/>
<dbReference type="DOI" id="10.1128/MCB.01530-07"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-130; SER-302; SER-304; SER-307 AND SER-664</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Blood" volume="114" first="3056" last="3063">
<title>Lyn, PKC-delta, SHIP-1 interactions regulate GPVI-mediated platelet-dense granule secretion.</title>
<authorList>
<person name="Chari R."/>
<person name="Kim S."/>
<person name="Murugappan S."/>
<person name="Sanjay A."/>
<person name="Daniel J.L."/>
<person name="Kunapuli S.P."/>
</authorList>
<dbReference type="PubMed" id="19587372"/>
<dbReference type="DOI" id="10.1182/blood-2008-11-188516"/>
</citation>
<scope>FUNCTION IN PLATELET RESPONSE</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-218; TYR-313 AND SER-664</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-313 AND SER-664</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="J. Leukoc. Biol." volume="87" first="153" last="164">
<title>Regulation of TNF-induced oxygen radical production in human neutrophils: role of delta-PKC.</title>
<authorList>
<person name="Kilpatrick L.E."/>
<person name="Sun S."/>
<person name="Li H."/>
<person name="Vary T.C."/>
<person name="Korchak H.M."/>
</authorList>
<dbReference type="PubMed" id="19801500"/>
<dbReference type="DOI" id="10.1189/jlb.0408230"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF NCF1</scope>
<scope>PHOSPHORYLATION AT THR-507 AND SER-645</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2002" name="J. Biochem." volume="132" first="831" last="839">
<title>Protein kinase C delta (PKC delta): activation mechanisms and functions.</title>
<authorList>
<person name="Kikkawa U."/>
<person name="Matsuzaki H."/>
<person name="Yamamoto T."/>
</authorList>
<dbReference type="PubMed" id="12473183"/>
<dbReference type="DOI" id="10.1093/oxfordjournals.jbchem.a003294"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="J. Thromb. Haemost." volume="8" first="454" last="462">
<title>Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation.</title>
<authorList>
<person name="Harper M.T."/>
<person name="Poole A.W."/>
</authorList>
<dbReference type="PubMed" id="20002545"/>
<dbReference type="DOI" id="10.1111/j.1538-7836.2009.03722.x"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304; TYR-374; SER-645 AND SER-664</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="ScientificWorldJournal" volume="10" first="2272" last="2284">
<title>Two faces of protein kinase Cdelta: the contrasting roles of PKCdelta in cell survival and cell death.</title>
<authorList>
<person name="Basu A."/>
<person name="Pal D."/>
</authorList>
<dbReference type="PubMed" id="21103796"/>
<dbReference type="DOI" id="10.1100/tsw.2010.214"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="J. Mol. Cell. Cardiol." volume="51" first="665" last="673">
<title>PKC-delta and PKC-epsilon: Foes of the same family or strangers?</title>
<authorList>
<person name="Duquesnes N."/>
<person name="Lezoualc'h F."/>
<person name="Crozatier B."/>
</authorList>
<dbReference type="PubMed" id="21810427"/>
<dbReference type="DOI" id="10.1016/j.yjmcc.2011.07.013"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304 AND SER-645</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2012" name="Arch. Immunol. Ther. Exp." volume="60" first="361" last="372">
<title>Protein kinase cdelta in apoptosis: a brief overview.</title>
<authorList>
<person name="Zhao M."/>
<person name="Xia L."/>
<person name="Chen G.Q."/>
</authorList>
<dbReference type="PubMed" id="22918451"/>
<dbReference type="DOI" id="10.1007/s00005-012-0188-8"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2013" name="Blood" volume="121" first="3112" last="3116">
<title>B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C delta.</title>
<authorList>
<person name="Salzer E."/>
<person name="Santos-Valente E."/>
<person name="Klaver S."/>
<person name="Ban S.A."/>
<person name="Emminger W."/>
<person name="Prengemann N.K."/>
<person name="Garncarz W."/>
<person name="Mullauer L."/>
<person name="Kain R."/>
<person name="Boztug H."/>
<person name="Heitger A."/>
<person name="Arbeiter K."/>
<person name="Eitelberger F."/>
<person name="Seidel M.G."/>
<person name="Holter W."/>
<person name="Pollak A."/>
<person name="Pickl W.F."/>
<person name="Forster-Waldl E."/>
<person name="Boztug K."/>
</authorList>
<dbReference type="PubMed" id="23319571"/>
<dbReference type="DOI" id="10.1182/blood-2012-10-460741"/>
</citation>
<scope>INVOLVEMENT IN ALPS3</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-141; SER-299; SER-302; SER-304; SER-307; SER-503 AND SER-664</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-664</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2017" name="Sci. Rep." volume="7" first="887" last="887">
<title>Differential regulation of PKD isoforms in oxidative stress conditions through phosphorylation of a conserved Tyr in the P+1 loop.</title>
<authorList>
<person name="Cobbaut M."/>
<person name="Derua R."/>
<person name="Doeppler H."/>
<person name="Lou H.J."/>
<person name="Vandoninck S."/>
<person name="Storz P."/>
<person name="Turk B.E."/>
<person name="Seufferlein T."/>
<person name="Waelkens E."/>
<person name="Janssens V."/>
<person name="Van Lint J."/>
</authorList>
<dbReference type="PubMed" id="28428613"/>
<dbReference type="DOI" id="10.1038/s41598-017-00800-w"/>
</citation>
<scope>INTERACTION WITH PRKD2</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2005" name="Cell" volume="121" first="271" last="280">
<title>The C2 domain of PKCdelta is a phosphotyrosine binding domain.</title>
<authorList>
<person name="Benes C.H."/>
<person name="Wu N."/>
<person name="Elia A.E.H."/>
<person name="Dharia T."/>
<person name="Cantley L.C."/>
<person name="Soltoff S.P."/>
</authorList>
<dbReference type="PubMed" id="15851033"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.02.019"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1-123 IN COMPLEX WITH PHOSPHOTYROSINE-CONTAINING PEPTIDE</scope>
<scope>INTERACTION WITH CDCP1</scope>
</reference>
<reference key="42">
<citation type="submission" date="2008-04" db="PDB data bank">
<title>Solution structure of the first phorbol esters/diacylglycerol binding domain of human protein kinase C, delta.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 149-218</scope>
</reference>
<comment type="function">
<text evidence="11 17 20 22 24 28 29 30">Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays contrasting roles in cell death and cell survival by functioning as a pro-apoptotic protein during DNA damage-induced apoptosis, but acting as an anti-apoptotic protein during cytokine receptor-initiated cell death, is involved in tumor suppression as well as survival of several cancers, is required for oxygen radical production by NADPH oxidase and acts as positive or negative regulator in platelet functional responses. Negatively regulates B cell proliferation and also has an important function in self-antigen induced B cell tolerance induction. Upon DNA damage, activates the promoter of the death-promoting transcription factor BCLAF1/Btf to trigger BCLAF1-mediated p53/TP53 gene transcription and apoptosis. In response to oxidative stress, interact with and activate CHUK/IKKA in the nucleus, causing the phosphorylation of p53/TP53. In the case of ER stress or DNA damage-induced apoptosis, can form a complex with the tyrosine-protein kinase ABL1 which trigger apoptosis independently of p53/TP53. In cytosol can trigger apoptosis by activating MAPK11 or MAPK14, inhibiting AKT1 and decreasing the level of X-linked inhibitor of apoptosis protein (XIAP), whereas in nucleus induces apoptosis via the activation of MAPK8 or MAPK9. Upon ionizing radiation treatment, is required for the activation of the apoptosis regulators BAX and BAK, which trigger the mitochondrial cell death pathway. Can phosphorylate MCL1 and target it for degradation which is sufficient to trigger for BAX activation and apoptosis. Is required for the control of cell cycle progression both at G1/S and G2/M phases. Mediates phorbol 12-myristate 13-acetate (PMA)-induced inhibition of cell cycle progression at G1/S phase by up-regulating the CDK inhibitor CDKN1A/p21 and inhibiting the cyclin CCNA2 promoter activity. In response to UV irradiation can phosphorylate CDK1, which is important for the G2/M DNA damage checkpoint activation. Can protect glioma cells from the apoptosis induced by TNFSF10/TRAIL, probably by inducing increased phosphorylation and subsequent activation of AKT1. Is highly expressed in a number of cancer cells and promotes cell survival and resistance against chemotherapeutic drugs by inducing cyclin D1 (CCND1) and hyperphosphorylation of RB1, and via several pro-survival pathways, including NF-kappa-B, AKT1 and MAPK1/3 (ERK1/2). Can also act as tumor suppressor upon mitogenic stimulation with PMA or TPA. In N-formyl-methionyl-leucyl-phenylalanine (fMLP)-treated cells, is required for NCF1 (p47-phox) phosphorylation and activation of NADPH oxidase activity, and regulates TNF-elicited superoxide anion production in neutrophils, by direct phosphorylation and activation of NCF1 or indirectly through MAPK1/3 (ERK1/2) signaling pathways. May also play a role in the regulation of NADPH oxidase activity in eosinophil after stimulation with IL5, leukotriene B4 or PMA. In collagen-induced platelet aggregation, acts a negative regulator of filopodia formation and actin polymerization by interacting with and negatively regulating VASP phosphorylation. Downstream of PAR1, PAR4 and CD36/GP4 receptors, regulates differentially platelet dense granule secretion; acts as a positive regulator in PAR-mediated granule secretion, whereas it negatively regulates CD36/GP4-mediated granule release. Phosphorylates MUC1 in the C-terminal and regulates the interaction between MUC1 and beta-catenin. The catalytic subunit phosphorylates 14-3-3 proteins (YWHAB, YWHAZ and YWHAH) in a sphingosine-dependent fashion (By similarity). Phosphorylates ELAVL1 in response to angiotensin-2 treatment (PubMed:18285462).</text>
</comment>
<comment type="catalytic activity">
<text evidence="28">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="catalytic activity">
<text evidence="16">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="11">Novel PKCs (PRKCD, PRKCE, PRKCH and PRKCQ) are calcium-insensitive, but activated by diacylglycerol (DAG) and phosphatidylserine. Three specific sites; Thr-507 (activation loop of the kinase domain), Ser-645 (turn motif) and Ser-664 (hydrophobic region), need to be phosphorylated for its full activation. Activated by caspase-3 (CASP3) cleavage during apoptosis. After cleavage, the pseudosubstrate motif in the regulatory subunit is released from the substrate recognition site of the catalytic subunit, which enables PRKCD to become constitutively activated. The catalytic subunit which displays properties of a sphingosine-dependent protein kinase is activated by D-erythro-sphingosine (Sph) or N,N-dimethyl-D-erythrosphingosine (DMS) or N,N,N-trimethyl-D-erythrosphingosine (TMS), but not by ceramide or Sph-1-P and is strongly inhibited by phosphatidylserine (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="13 19 20 21 23 24 32">Interacts with PDPK1 (via N-terminal region) (PubMed:11781095). Interacts with RAD9A (PubMed:12628935). Interacts with CDCP1 (PubMed:15851033). Interacts with MUC1 (PubMed:11877440). Interacts with VASP (PubMed:16940418). Interacts with CAVIN3 (By similarity). Interacts with PRKD2 (via N-terminus and zing-finger domain 1 and 2) in response to oxidative stress; the interaction is independent of PRKD2 tyrosine phosphorylation (PubMed:28428613).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-704279"/>
<interactant intactId="EBI-7006141">
<id>Q9BXL7</id>
<label>CARD11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-704279"/>
<interactant intactId="EBI-517508">
<id>Q9NR28</id>
<label>DIABLO</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-704279"/>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-704279"/>
<interactant intactId="EBI-1267511">
<id>P17677</id>
<label>GAP43</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-704279"/>
<interactant intactId="EBI-9547476">
<id>C6GKH1</id>
<label>IL32</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-704279"/>
<interactant intactId="EBI-8800907">
<id>P24001-2</id>
<label>IL32</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-704279"/>
<interactant intactId="EBI-489611">
<id>P19878</id>
<label>NCF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-704279"/>
<interactant intactId="EBI-539628">
<id>P11388</id>
<label>TOP2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-704279"/>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-704279"/>
<interactant intactId="EBI-2337775">
<id>Q9H3D4</id>
<label>TP63</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="22 26 28">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="22 26">Cytoplasm</location>
<location evidence="22 26">perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="22 26 28">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="26">Cell membrane</location>
<topology evidence="38">Peripheral membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q05655-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q05655-2</id>
<name>2</name>
<name>PKCdeltaVIII</name>
<sequence type="described" ref="VSP_043899"/>
<text>Antiapoptotic isoform, resistant to caspase-3 cleavage.</text>
</isoform>
</comment>
<comment type="domain">
<text>The C1 domain, containing the phorbol ester/DAG-type region 1 (C1A) and 2 (C1B), is the diacylglycerol sensor.</text>
</comment>
<comment type="domain">
<text>The C2 domain is a non-calcium binding domain. It binds proteins containing phosphotyrosine in a sequence-specific manner.</text>
</comment>
<comment type="PTM">
<text evidence="19 22 25 26 30">Autophosphorylated and/or phosphorylated at Thr-507, within the activation loop; phosphorylation at Thr-507 is not a prerequisite for enzymatic activity. Autophosphorylated at Ser-299, Ser-302 and Ser-304. Upon TNFSF10/TRAIL treatment, phosphorylated at Tyr-155; phosphorylation is required for its translocation to the endoplasmic reticulum and cleavage by caspase-3. Phosphorylated at Tyr-313, Tyr-334 and Tyr-567; phosphorylation of Tyr-313 and Tyr-567 following thrombin stimulation potentiates its kinase activity. Phosphorylated by protein kinase PDPK1; phosphorylation is inhibited by the apoptotic C-terminal cleavage product of PKN2.</text>
</comment>
<comment type="PTM">
<text evidence="11">Proteolytically cleaved into a catalytic subunit and a regulatory subunit by caspase-3 during apoptosis which results in kinase activation.</text>
</comment>
<comment type="disease" evidence="31">
<disease id="DI-03976">
<name>Autoimmune lymphoproliferative syndrome 3</name>
<acronym>ALPS3</acronym>
<description>A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low. CVID9 patients have B-cell deficiency and severe autoimmunity.</description>
<dbReference type="MIM" id="615559"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="36">Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PRKCDID42901ch3p21.html"/>
</comment>
<dbReference type="EC" id="2.7.11.13" evidence="28"/>
<dbReference type="EC" id="2.7.10.2"/>
<dbReference type="EMBL" id="L07860">
<property type="protein sequence ID" value="AAA03176.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L07861">
<property type="protein sequence ID" value="AAA03175.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313216">
<property type="protein sequence ID" value="BAG36031.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471055">
<property type="protein sequence ID" value="EAW65279.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC043350">
<property type="protein sequence ID" value="AAH43350.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z22521">
<property type="protein sequence ID" value="CAA80249.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D10495">
<property type="protein sequence ID" value="BAA01381.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ516383">
<property type="protein sequence ID" value="ABF68960.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2870.1">
<molecule id="Q05655-1"/>
</dbReference>
<dbReference type="PIR" id="S35704">
<property type="entry name" value="S35704"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001303256.1">
<molecule id="Q05655-1"/>
<property type="nucleotide sequence ID" value="NM_001316327.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_006245.2">
<molecule id="Q05655-1"/>
<property type="nucleotide sequence ID" value="NM_006254.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_997704.1">
<molecule id="Q05655-1"/>
<property type="nucleotide sequence ID" value="NM_212539.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006713322.1">
<property type="nucleotide sequence ID" value="XM_006713259.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016862344.1">
<property type="nucleotide sequence ID" value="XM_017006855.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016862345.1">
<molecule id="Q05655-1"/>
<property type="nucleotide sequence ID" value="XM_017006856.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.155342"/>
<dbReference type="PDB" id="1YRK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1-123"/>
</dbReference>
<dbReference type="PDB" id="2YUU">
<property type="method" value="NMR"/>
<property type="chains" value="A=149-218"/>
</dbReference>
<dbReference type="PDBsum" id="1YRK"/>
<dbReference type="PDBsum" id="2YUU"/>
<dbReference type="ProteinModelPortal" id="Q05655"/>
<dbReference type="SMR" id="Q05655"/>
<dbReference type="BioGrid" id="111566">
<property type="interactions" value="98"/>
</dbReference>
<dbReference type="CORUM" id="Q05655"/>
<dbReference type="DIP" id="DIP-29954N"/>
<dbReference type="ELM" id="Q05655"/>
<dbReference type="IntAct" id="Q05655">
<property type="interactions" value="49"/>
</dbReference>
<dbReference type="MINT" id="MINT-1346366"/>
<dbReference type="STRING" id="9606.ENSP00000331602"/>
<dbReference type="BindingDB" id="Q05655"/>
<dbReference type="ChEMBL" id="CHEMBL2996"/>
<dbReference type="DrugBank" id="DB04376">
<property type="generic name" value="13-Acetylphorbol"/>
</dbReference>
<dbReference type="DrugBank" id="DB05013">
<property type="generic name" value="Ingenol Mebutate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00675">
<property type="generic name" value="Tamoxifen"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1485"/>
<dbReference type="iPTMnet" id="Q05655"/>
<dbReference type="PhosphoSitePlus" id="Q05655"/>
<dbReference type="BioMuta" id="PRKCD"/>
<dbReference type="DMDM" id="205371776"/>
<dbReference type="EPD" id="Q05655"/>
<dbReference type="MaxQB" id="Q05655"/>
<dbReference type="PaxDb" id="Q05655"/>
<dbReference type="PeptideAtlas" id="Q05655"/>
<dbReference type="PRIDE" id="Q05655"/>
<dbReference type="DNASU" id="5580"/>
<dbReference type="Ensembl" id="ENST00000330452">
<molecule id="Q05655-1"/>
<property type="protein sequence ID" value="ENSP00000331602"/>
<property type="gene ID" value="ENSG00000163932"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000394729">
<molecule id="Q05655-1"/>
<property type="protein sequence ID" value="ENSP00000378217"/>
<property type="gene ID" value="ENSG00000163932"/>
</dbReference>
<dbReference type="GeneID" id="5580"/>
<dbReference type="KEGG" id="hsa:5580"/>
<dbReference type="UCSC" id="uc003dgl.4">
<molecule id="Q05655-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5580"/>
<dbReference type="DisGeNET" id="5580"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000163932.13"/>
<dbReference type="GeneCards" id="PRKCD"/>
<dbReference type="HGNC" id="HGNC:9399">
<property type="gene designation" value="PRKCD"/>
</dbReference>
<dbReference type="HPA" id="CAB010469"/>
<dbReference type="HPA" id="CAB013225"/>
<dbReference type="HPA" id="HPA001863"/>
<dbReference type="HPA" id="HPA001890"/>
<dbReference type="MalaCards" id="PRKCD"/>
<dbReference type="MIM" id="176977">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615559">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q05655"/>
<dbReference type="OpenTargets" id="ENSG00000163932"/>
<dbReference type="Orphanet" id="3261">
<property type="disease" value="Autoimmune lymphoproliferative syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="300345">
<property type="disease" value="Autosomal recessive systemic lupus erythematosus"/>
</dbReference>
<dbReference type="Orphanet" id="1572">
<property type="disease" value="Common variable immunodeficiency"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33763"/>
<dbReference type="eggNOG" id="KOG0694">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XNPH">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00820000126964"/>
<dbReference type="HOGENOM" id="HOG000233022"/>
<dbReference type="HOVERGEN" id="HBG108317"/>
<dbReference type="InParanoid" id="Q05655"/>
<dbReference type="KO" id="K06068"/>
<dbReference type="OMA" id="FIFHKVL"/>
<dbReference type="OrthoDB" id="EOG091G0QRS"/>
<dbReference type="PhylomeDB" id="Q05655"/>
<dbReference type="TreeFam" id="TF102004"/>
<dbReference type="BRENDA" id="2.7.11.13">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-111465">
<property type="pathway name" value="Apoptotic cleavage of cellular proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-111933">
<property type="pathway name" value="Calmodulin induced events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-114508">
<property type="pathway name" value="Effects of PIP2 hydrolysis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250196">
<property type="pathway name" value="SHC1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1489509">
<property type="pathway name" value="DAG and IP3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029485">
<property type="pathway name" value="Role of phospholipids in phagocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418597">
<property type="pathway name" value="G alpha (z) signalling events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450520">
<property type="pathway name" value="HuR (ELAVL1) binds and stabilizes mRNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5218921">
<property type="pathway name" value="VEGFR2 mediated cell proliferation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5607764">
<property type="pathway name" value="CLEC7A (Dectin-1) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-877300">
<property type="pathway name" value="Interferon gamma signaling"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q05655"/>
<dbReference type="SignaLink" id="Q05655"/>
<dbReference type="SIGNOR" id="Q05655"/>
<dbReference type="ChiTaRS" id="PRKCD">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q05655"/>
<dbReference type="GeneWiki" id="PRKCD"/>
<dbReference type="GenomeRNAi" id="5580"/>
<dbReference type="PMAP-CutDB" id="Q05655"/>
<dbReference type="PRO" id="PR:Q05655"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000163932"/>
<dbReference type="CleanEx" id="HS_PRKCD"/>
<dbReference type="ExpressionAtlas" id="Q05655">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q05655">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0035578">
<property type="term" value="C:azurophil granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005911">
<property type="term" value="C:cell-cell junction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016363">
<property type="term" value="C:nuclear matrix"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004699">
<property type="term" value="F:calcium-independent protein kinase C activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008047">
<property type="term" value="F:enzyme activator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043560">
<property type="term" value="F:insulin receptor substrate binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004697">
<property type="term" value="F:protein kinase C activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032147">
<property type="term" value="P:activation of protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042100">
<property type="term" value="P:B cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060326">
<property type="term" value="P:cell chemotaxis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:1904385">
<property type="term" value="P:cellular response to angiotensin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071447">
<property type="term" value="P:cellular response to hydroperoxide"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090398">
<property type="term" value="P:cellular senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042742">
<property type="term" value="P:defense response to bacterium"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097194">
<property type="term" value="P:execution phase of apoptosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038096">
<property type="term" value="P:Fc-gamma receptor signaling pathway involved in phagocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016572">
<property type="term" value="P:histone phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016064">
<property type="term" value="P:immunoglobulin mediated immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060333">
<property type="term" value="P:interferon-gamma-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032613">
<property type="term" value="P:interleukin-10 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032615">
<property type="term" value="P:interleukin-12 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008631">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to oxidative stress"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030837">
<property type="term" value="P:negative regulation of actin filament polymerization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051490">
<property type="term" value="P:negative regulation of filopodium assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034351">
<property type="term" value="P:negative regulation of glial cell apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050728">
<property type="term" value="P:negative regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046627">
<property type="term" value="P:negative regulation of insulin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043407">
<property type="term" value="P:negative regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050732">
<property type="term" value="P:negative regulation of peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090331">
<property type="term" value="P:negative regulation of platelet aggregation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032091">
<property type="term" value="P:negative regulation of protein binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042119">
<property type="term" value="P:neutrophil activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018107">
<property type="term" value="P:peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:2001235">
<property type="term" value="P:positive regulation of apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000304">
<property type="term" value="P:positive regulation of ceramide biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032079">
<property type="term" value="P:positive regulation of endodeoxyribonuclease activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000753">
<property type="term" value="P:positive regulation of glucosylceramide catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900163">
<property type="term" value="P:positive regulation of phospholipid scramblase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035307">
<property type="term" value="P:positive regulation of protein dephosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042307">
<property type="term" value="P:positive regulation of protein import into nucleus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001022">
<property type="term" value="P:positive regulation of response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000755">
<property type="term" value="P:positive regulation of sphingomyelin catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032930">
<property type="term" value="P:positive regulation of superoxide anion generation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032956">
<property type="term" value="P:regulation of actin cytoskeleton organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0043488">
<property type="term" value="P:regulation of mRNA stability"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010469">
<property type="term" value="P:regulation of receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0023021">
<property type="term" value="P:termination of signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="CDD" id="cd00029">
<property type="entry name" value="C1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="CDD" id="cd05620">
<property type="entry name" value="STKc_nPKC_delta"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.150">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000961">
<property type="entry name" value="AGC-kinase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR035892">
<property type="entry name" value="C2_domain_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR020454">
<property type="entry name" value="DAG/PE-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR034667">
<property type="entry name" value="nPKC_delta"/>
</dbReference>
<dbReference type="InterPro" id="IPR002219">
<property type="entry name" value="PE/DAG-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR027436">
<property type="entry name" value="PKC_delta"/>
</dbReference>
<dbReference type="InterPro" id="IPR017892">
<property type="entry name" value="Pkinase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR014376">
<property type="entry name" value="Prot_kin_PKC_delta"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00130">
<property type="entry name" value="C1_1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00433">
<property type="entry name" value="Pkinase_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000551">
<property type="entry name" value="PKC_delta"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF501104">
<property type="entry name" value="Protein_kin_C_delta"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00008">
<property type="entry name" value="DAGPEDOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00109">
<property type="entry name" value="C1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00133">
<property type="entry name" value="S_TK_X"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49562">
<property type="entry name" value="SSF49562"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51285">
<property type="entry name" value="AGC_KINASE_CTER"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00479">
<property type="entry name" value="ZF_DAG_PE_1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50081">
<property type="entry name" value="ZF_DAG_PE_2"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Protein kinase C delta type" id="PRO_0000055694">
<location>
<begin position="1"/>
<end position="676"/>
</location>
</feature>
<feature type="chain" description="Protein kinase C delta type regulatory subunit" id="PRO_0000421667" evidence="11">
<location>
<begin position="1"/>
<end position="329"/>
</location>
</feature>
<feature type="chain" description="Protein kinase C delta type catalytic subunit" id="PRO_0000421668" evidence="11">
<location>
<begin position="330"/>
<end position="676"/>
</location>
</feature>
<feature type="domain" description="C2">
<location>
<begin position="1"/>
<end position="90"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="14">
<location>
<begin position="349"/>
<end position="603"/>
</location>
</feature>
<feature type="domain" description="AGC-kinase C-terminal">
<location>
<begin position="604"/>
<end position="675"/>
</location>
</feature>
<feature type="zinc finger region" description="Phorbol-ester/DAG-type 1" evidence="15">
<location>
<begin position="158"/>
<end position="208"/>
</location>
</feature>
<feature type="zinc finger region" description="Phorbol-ester/DAG-type 2" evidence="15">
<location>
<begin position="230"/>
<end position="280"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="14">
<location>
<begin position="355"/>
<end position="363"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="14 16">
<location>
<position position="473"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="14">
<location>
<position position="378"/>
</location>
</feature>
<feature type="site" description="Interaction with phosphotyrosine-containing peptide">
<location>
<position position="48"/>
</location>
</feature>
<feature type="site" description="Interaction with phosphotyrosine-containing peptide">
<location>
<position position="62"/>
</location>
</feature>
<feature type="site" description="Interaction with phosphotyrosine-containing peptide">
<location>
<position position="67"/>
</location>
</feature>
<feature type="site" description="Interaction with phosphotyrosine-containing peptide">
<location>
<position position="123"/>
</location>
</feature>
<feature type="site" description="Cleavage; by caspase-3" evidence="11">
<location>
<begin position="329"/>
<end position="330"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="13">
<location>
<position position="43"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="27">
<location>
<position position="50"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="12">
<location>
<position position="64"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="130"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9 27">
<location>
<position position="141"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="22">
<location>
<position position="155"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5">
<location>
<position position="218"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="4 9 26">
<location>
<position position="299"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="3 9 26">
<location>
<position position="302"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="3 7 8 9 26 27">
<location>
<position position="304"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 9">
<location>
<position position="307"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="4 5 6 25">
<location>
<position position="313"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by SRC" evidence="37">
<location>
<position position="334"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="7">
<location>
<position position="374"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="27">
<location>
<position position="451"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 9">
<location>
<position position="503"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="27">
<location>
<position position="506"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="27 39">
<location>
<position position="507"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="25">
<location>
<position position="567"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 8 30">
<location>
<position position="645"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="654"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="658"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 5 6 7 9 10 27">
<location>
<position position="664"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_043899" evidence="35">
<original>Q</original>
<variation>QGEAGSIAPLRFLFPLRPKKGDCPPFHCQVRQ</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs33911937." id="VAR_035347">
<original>N</original>
<variation>S</variation>
<location>
<position position="348"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1056998." id="VAR_006175" evidence="34">
<original>F</original>
<variation>S</variation>
<location>
<position position="375"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34502209." id="VAR_035348">
<original>L</original>
<variation>F</variation>
<location>
<position position="410"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35891605." id="VAR_046009">
<original>R</original>
<variation>W</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_020610" evidence="33">
<original>M</original>
<variation>V</variation>
<location>
<position position="494"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_006176" evidence="34">
<original>V</original>
<variation>M</variation>
<location>
<position position="593"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation." evidence="26">
<original>S</original>
<variation>A</variation>
<location>
<position position="299"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on kinase activity." evidence="18">
<original>T</original>
<variation>A</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG36031." ref="2" evidence="36">
<original>K</original>
<variation>R</variation>
<location>
<position position="524"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; no nucleotide entry." ref="8" evidence="36">
<original>S</original>
<variation>A</variation>
<location>
<position position="533"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1"/>
<end position="13"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="20"/>
<end position="23"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="27"/>
<end position="38"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="41"/>
<end position="45"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="58"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="68"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="79"/>
<end position="87"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="88"/>
<end position="96"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="97"/>
<end position="100"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="101"/>
<end position="107"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="109"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="113"/>
<end position="123"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="156"/>
<end position="158"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="161"/>
<end position="164"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="173"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="186"/>
<end position="189"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="190"/>
<end position="192"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="200"/>
<end position="202"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1YRK"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2YUU"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250"/>
<evidence key="12" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P09215"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P28867"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00226"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11748588"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11772397"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11781095"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11877440"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12628935"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15774464"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15851033"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16940418"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17570831"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17603046"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17965192"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18285462"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19587372"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19801500"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23319571"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28428613"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7988719"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8357834"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18092819"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000305"/>
<evidence key="37" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11781095"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="17603046"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19801500"/>
</source>
</evidence>
<sequence length="676" mass="77505" checksum="013F4314A2EE331A" modified="2008-09-02" version="2">
MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFD
AHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQY
FLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVW
GLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMS
PTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASR
RSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSF
GKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTK
DHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVL
LDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYE
MLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIH
PFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAF
AGFSFVNPKFEHLLED
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>